Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 3,17€(−24,70%). Der Median liegt bei 3,17€(−24,70%).
| Kaufen | 3 |
| Halten | 1 |
| Verkaufen | 0 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
23andMe bankruptcy under congressional investigation for customer data
The House Committee on Energy and Commerce sent a letter to 23andMe expressing concern that its genetic data is "at risk of being compromised." The embattled genetic testing company filed for Chapter 11 bankruptcy protection in March, and its assets are up for sale.» Mehr auf cnbc.com
US House committee seeks testimony from 23andMe co-founder after bankruptcy
A U.S. House committee on Monday asked 23andMe's co-founder to testify next month as it launched an investigation into the risk of genetic data being transferred to potential buyers amid the DNA testing company's bankruptcy.» Mehr auf reuters.com
23andMe probe launched to prevent customer DNA data from being sold to China or other bad actors
Sen. Bill Cassidy is probing 23andMe, which recently filed for bankruptcy protection, to ensure the company does not sell customer data to China or other foreign adversaries.» Mehr auf foxbusiness.com
Unternehmenszahlen
| (EUR) | März 2025 | |
|---|---|---|
| Umsatz | 41,73 Mio | 29,65% |
| Bruttoeinkommen | 16,19 Mio | 35,37% |
| Nettoeinkommen | −91,83 Mio | 52,54% |
| EBITDA | −39,12 Mio | 79,19% |
Fundamentaldaten
| Metrik | Wert |
|---|---|
Marktkapitalisierung | 11,41 Mio€ |
Anzahl Aktien | 21,99 Mio |
52 Wochen-Hoch/Tief | 10,91€ - 0,41€ |
| Dividenden | Nein |
Beta | 1,2 |
KGV (PE Ratio) | −0,06 |
KGWV (PEG Ratio) | 0,00 |
KBV (PB Ratio) | −0,58 |
KUV (PS Ratio) | 0,07 |
Unternehmensprofil
| Name | 23ANDME HLDG A DL -,0001 Aktie |
| CEO | Joseph Selsavage |
| Mitarbeiter | 560 |
Assets entdecken
Shareholder von 23ANDME HLDG A DL -,0001 Aktie investieren auch in folgende Assets
